FDA Moves to Ban Ineffective Decongestant from Cold Medicines
TL;DR
The FDA has proposed removing oral phenylephrine, a common ingredient in over-the-counter cold and cough medicines, citing its ineffectiveness as a nasal decongestant. This proposal follows a unanimous vote by an expert panel against its efficacy. The FDA is seeking public comments on the proposal, and companies can continue selling products with oral phenylephrine for now. The Consumer Healthcare Products Association expressed disappointment with the FDA's decision, while companies like Procter & Gamble and GSK have yet to comment.
- FDA proposes ending use of popular decongestant present in cold medicines New York Post
- FDA proposes ending use of decongestant found in many cold, allergy medicines CNBC
- FDA to pull common but ineffective cold medicine from market CBS News
- FDA Wants to Ban Popular but Ineffective Cold Remedy Ingredient The Wall Street Journal
- FDA wants to remove popular decongestants from stores permanently that contain this ingredient WSB Atlanta
Want the full story? Read the original reporting
Read on New York Post